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Intermittent fetal heart rate monitoring
using a fetoscope or hand held Doppler
in rural Tanzania: a randomized controlled
trial
Paschal Francis Mdoe1,2,8*, Hege L. Ersdal2,3, Estomih R. Mduma1,2, Jeffrey M. Perlman4, Robert Moshiro2,7,
Peter T. Wangwe6 and Hussein Kidanto5,6
Abstract
Background: Neonatal mortality is a global challenge, with an estimated 1.3 million intrapartum stillbirths in 2015.
The majority of these were found in low resource settings with limited options to intrapartum fetal heart monitoring
devices. This trial compared frequency of abnormal fetal heart rate (FHR) detection and adverse perinatal outcomes (i.e.
fresh stillbirths, 24-h neonatal deaths, admission to neonatal care unit) among women intermittently assessed
by Doppler or fetoscope in a rural low-resource setting.
Methods: This was an open-label randomized controlled trial conducted at Haydom Lutheran Hospital from
March 2013 through August 2015. Inclusion criteria were; women in labor, singleton, cephalic presentation,
normal FHR on admission (120–160 beats/minute), and cervical dilatation ≤7 cm. Verbal consent was obtained.
Results: A total of 2684 women were recruited, 1309 in the Doppler and 1375 in the fetoscope arms, respectively.
Abnormal FHR was detected in 55 (4.2%) vs 42 (3.1%). (RR = 1.38; 95%CI: 0.93, 2.04) in the Doppler and fetoscope arms,
respectively. Bag mask ventilation was performed in 80 (6.1%) vs 82 (6.0%). (RR = 1.03; 95%CI: 0.76, 1.38) of neonates,
and adverse perinatal outcome was comparable 32(2.4%) vs 35(2.5%). (RR = 0.9; 95%CI: 0.59, 1.54), in the Doppler and
fetoscope arms, respectively.
Conclusion: This trial failed to demonstrate a statistically significant difference in the detection of abnormal FHR
between intermittently used Doppler and fetoscope and adverse perinatal outcomes. However, FHR measurements
were not performed as often as recommended by international guidelines. Conducting a randomized controlled study
in rural settings with limited resources is associated with major challenges.
Trial registration: This clinical trial was registered on April 2013 with registration number NCT01869582.
Keywords: Intermittent fetal heart rate monitoring, Pinard fetoscope, Doppler
Background
Globally, an estimated 1.2 million fresh stillbirths (FSB)
and 2.1 early neonatal deaths (END) occurred in 2013,
98% in low and middle-income countries [1–4]. Cur-
rently, the proportion of neonatal deaths constitute 44%
of under-five child mortality [5]. Intrapartum hypoxia
(often defined as birth asphyxia) has been reported to be
associated with as much as 70% of FSB and 60% of END
[6–9]. Identification and timely management of intrapar-
tum hypoxia is therefore a priority area for reducing
perinatal mortality in low resource countries.
Intrapartum fetal heart rate (FHR) monitoring aims at
recognizing the hypoxic fetus as a result of fetal inter-
ruption of placental blood flow during labor. FHR trac-
ings can reveal specific information regarding fetal
oxygenation. Thus, an abnormal FHR tracing (i.e. late
deceleration, severe variability, bradycardia and tachycar-
dia) during the first stage of labor has been associated
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with fetal hypoxia and fetal acidosis [10–12], and intermit-
tently detected abnormal FHR has been associated with
adverse perinatal outcome in a rural setting [13]. Several
studies from resource replete settings have reported lower
rate of operative deliveries (i.e. cesarean section, vacuum
or forceps extraction) when comparing intermittent to
continuous FHR monitoring, respectively [14, 15].
Importantly, in these studies, intermittent FHR assess-
ments were performed according to recommended guide-
lines i.e. optimal frequency and length of measurements.
In low resource settings, FHR monitoring is mainly
performed intermittently, using a Pinard fetoscope.
However, in 1994 in an urban hospital in Harare, a
hand-held Doppler ultrasound was found to be more ef-
fective in detecting abnormal FHR and improved peri-
natal outcome in low risk deliveries as compared to the
Pinard fetoscope [16]. The hand-held Doppler allows the
care provider to assess FHR quickly, to communicate
with the mother who can hear the heart sounds of her
baby hence increase maternal confidence concerning the
wellbeing of her unborn baby, and it is preferred by
women over the use of fetoscope [17, 18]. Main barriers
toward the more widely use of Doppler in low-resource
countries have been costs and lack of reliable electricity
supply. Therefore, a wind-up hand-held Doppler device
has been developed using a hand-crank to generate
power, that last for about 2 h for every 30-s of cracking
[19]. This wind-up Doppler was tested in a low resource
setting and found to be accurate and acceptable to
mothers as well as midwives [19]. A recent randomized
controlled study, comparing the Free-Play Doppler to
the Pinard fetoscope in a peri-urban setting in Uganda,
reported an increased detection rate of abnormal FHR in
the Doppler arm (7.6%) as compared to the Pinard arm
(4.7%), but no improvement of perinatal outcome [20].
To our knowledge, intermittent FHR monitoring using
Doppler or fetoscope has never been compared in a
rural sub-Saharan setting that differs substantially from
(peri-) urban settings. The aim of this study was to
compare the Free-Play Doppler with the Pinard feto-
scope for intermittent FHR monitoring, detection of
abnormal FHR and impact on perinatal outcomes in a
low-resource rural hospital.
Methods
We conducted a randomized control trial comparing the
Pinard fetoscope and Free-Play Doppler (Free Play,
Power-free Education Technology, Pet.og.za) for inter-
mittent FHR monitoring from March 2013 through Au-
gust 2015. Data collection was carried out at Haydom
Lutheran Hospital (HLH), a rural referral hospital in
Northern Tanzania. The hospital provides comprehen-
sive emergency obstetric care and basic newborn care to
a population of approximately 500,000 people, while the
greater reference area covers about 2 million people
[21]. Midwives largely conduct uncomplicated deliveries,
and doctors on call for 24 h perform operative deliveries.
Traditionally, FHR is routinely monitored by the attend-
ing midwife using a Pinard fetoscope. For this study, the
wind-up hand-held Free-Play Doppler was introduced.
All midwives and doctors were initially trained and then
retrained after every six months on how to use the Dop-
pler and simultaneously reminded about abnormal FHR
patterns and its obstetrical management. Midwives were
allowed to use Doppler, if available, also for deliveries
not included in the study.
Study population and randomization
The inclusion criteria are listed in Table 1. Recruitment,
information about the study, and verbal consent was ob-
tained by the admitting midwife in the admission room.
Women who consented were randomly allocated using
sealed opaque envelops. The allocation label was stapled
to the patient file, and the selected device (Doppler or
fetoscope) used for that woman.
Data collection
Research assistants were continuously present in the
labor ward, observing every delivery. They worked in
three shifts over 24 h. Three research assistants covered
each shift; two research assistants were always in the
delivery rooms or in the operating theatre; one in the
adjacent neonatal area. Altogether 14 research assistants
were trained to observe health care workers’ perform-
ance related to deliveries and newborns. Findings were
recorded on a data collection form. This included labor
progress information and FHR categorized as normal
(120 to 160 beats/minute), abnormal (< 120 or > 160
beats/minutes), absent, or not measured; specific device
used for FHR assessment; neonatal characteristics and
interventions in the delivery room, and perinatal out-
come (normal, admitted neonatal area, death within
24 h and FSB). The frequency of FHR monitoring was
not recorded, though midwives were expected to follow
WHO guidelines of monitoring FHR every 30 min dur-
ing the first and after five to 15 min during the second
stage of labor. Therefore, categorization of FHR was
Table 1 Inclusion criteria
• In labor (i.e. cervical dilatation ≥3 cm with uterine contractions)
• Singleton
• Cephalic presentation
• Gestation age ≥ 36 weeks
• Cervical dilatation ≤7 cm
• Normal FHR at admission
• Able to give verbal consent
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based on multiple measurements throughout labor. Ab-
normal FHR was reached after at least one confirmed
measurement at any point during labor.
Maternal age was based on self-report of the
mother or close relative. Maternal gravidity was the
number of pregnancies the woman had ever had in-
cluding the current one. Gestational age (GA) was
based on self-report of the last menstrual period and
distance from symphysis pubis to fundus (on admis-
sion). Normal term GA at HLH is routinely defined
as ≥ 36 weeks (Thus, preterm was defined as GA <
36 weeks and post term as > 42 weeks.
Normal perinatal outcome was defined as a live birth
and included all of the following; Apgar score more than
seven at one and five minutes, not admitted to the neo-
natal unit. Intrapartum death/FSB was defined as an
Apgar score of zero at both one and five minutes with
intact skin and suspected death during labor/delivery i.e.
with a FHR heard on admission. Antepartum death/
macerated stillbirth (MSB) was defined as an Apgar
score of zero at both one and five minutes with macer-
ated skin and suspected death before start of labor.
“FHR abnormalities” included abnormal or not detected.
There were some cases where the FHR was not
measured. “Adverse outcome” included FSB, neonatal
deaths within the first 24 h and infants still admitted in
the neonatal unit after 24 h.
Quality assurance of the data
The research assistants were trained, supervised, and
continuously re-trained by the first author. All data col-
lection forms were controlled for quality issues, before
entering to the computer, including missing information
and potential errors, on a daily basis. Data were double
entered using SPSS Version 22 by two different data
clerks.
Sample size and statistical consideration
Primary outcome measure was detection of an abnormal
FHR. A previous study at HLH revealed an abnormal
FHR detection rate of 2.7% in the total cohort when
using the Pinard fetoscope [13]. Based on this study, an
80% increase in detection rate was estimated for the Free
Play Doppler arm i.e. 4.8%, equivalent to the proportion
of abnormal FHR detection when using Pinard in the
peri-urban setting in Uganda [20]. An estimated 1277
cases were required in each arm to achieve a power of
80% using a two-sided test with significance level 0.05. A
total of 2684 cases were included, 5% more than the
calculated sample, to compensate for potentially missing
variables. Data was analyzed using the Statistical Package
for the Social Sciences (SPSS) v.22. Chi-square calcula-
tions and Fisher’s exact test were used to compare
categorical variables, and independent samples t-test
were used for continuous data.
Ethical considerations
Ethical clearances were granted by the Muhimbili
University of Health and Allied Sciences ethics and pub-
lication committee, and the Regional Committee for
Medical and Health Research Ethics, Western Norway
(2013/110/REK vest). Verbal consent was approved to be
used in this trial. Permission to collect data was granted
by the management at HLH. The trial was registered in
ClinicalTrials.gov Identifier NCT01869582.
Results
General characteristics of the whole cohort
During the study period 11,045 women delivered in
HLH (Fig. 1). Mean maternal age was 25.1 ± 6.5 years.
Almost 99% had attended antenatal care at least once,
and 1.0% reported some type of pregnancy problems.
The proportion of preterm delivery was 3.3%. Mean
birth weight (BW) was 3202 ± 529 g, and 880 (8%) neo-
nates had BW less than 2500 g. On admission, 114 (1.
0%) had an abnormal FHR, 217 (2.0%) had an undetect-
able FHR, and 1027 (9.3%) were not assessed. During
labor, irrespective of device used, abnormal FHR was de-
tected in 387 (3.5%) women. Overall, the mean time
interval from admission to detection of an abnormal
FHR was 6.5 ± 6.7 h, from the first detected abnormal
FHR to birth 120 ± 210 min, and from the final recorded
FHR assessment to birth was 92 ± 210 min. The majority
of women delivered vaginally, i.e. 8455 (76.6%),
whereas 2438 (22.1%) were delivered via caesarean
section (CS). Apgar scores less than seven at one and
five minutes were encountered in 392 (3.5%) and 66
(0.6%) neonates, respectively. There were150 (1.4%)
MSB, 155 (1.4%) FSB, 90 (0.8%) deaths within 24 h
after birth and 357 (3.2%) neonates admitted to the
neonatal unit for more than 24 h.
A total of 4914 women did not meet the inclusion cri-
teria, 20.9% (1027/4914) of these due to lack of FHR as-
sessment on admission. A sub-population of 6131
women met the inclusion criteria for the study. Of these
3447 (56.2%) women were not included because either
they refused (n = 2952) or consent was not taken (n =
495) (Fig. 1). This resulted in 2684 (43.8%) women who
were randomized. A comparison of general characteris-
tics of the women and neonates in the consented and
non-consented groups is presented in Table 2. There
was a significantly higher incidence of the FHR not be-
ing measured during labor in the non-consented group
(1.7%) as compared to the consented (0.5%) group, and
the CS and FSB rates were higher in the non-consented
as compared to the consented group (Table 3).
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A total of 1375 and 1309 women were randomized to
the fetoscope and the Doppler arm, respectively
(Table 4). Maternal mean age was comparable in the two
arms. There were more primigravid women in the feto-
scope arm as compared to the Doppler arm, 48.5% vs.
45.2%, respectively (p = 0.04).
Comparison of outcome measures in the two arms are
presented in Table 5. The detection of abnormal FHR
was higher in the Doppler arm as compared to the feto-
scope arm (p = 0.109). The time interval from the final
recorded FHR (normal or abnormal) to birth was similar
in the two arms, but much longer than recommended.
The time interval from the first abnormal FHR measure
to birth was comparable between the groups. Apgar
scores at one and five minutes, neonates receiving bag
mask ventilation, and adverse perinatal outcomes were
comparable.
Among the 8361 deliveries not included in the
randomization study, the type of device used for FHR
assessments was noted in 6360 women. The fetoscope
was preferred in 4104 (64.5%) cases and Doppler in 1036
(12.4%) cases. No device was used in 1220 (19.2%) cases.
Discussion
This trial failed to demonstrate significant differences in
detection of FHR abnormalities and 24-h perinatal out-
comes between Pinard fetoscope versus the Free-Play
Doppler when used for intermittent FHR assessments
during labor. However, several other important findings
related to intermittent FHR monitoring and major chal-
lenges associated with conducting a randomized trial in
such a rural setting are highlighted.
Doppler was almost 1.4 times more likely to detect ab-
normal FHR as compared to the fetoscope, however, this
was not statistically significant, representing a potential
type 2 error. Furthermore, abnormal FHR detection
rates, in both arms, were lower in this study as com-
pared to previous studies of similar design [16, 20].
Mahomed et al. reported 32% abnormal FHRs and de-
creased perinatal mortality when using a standard Dop-
pler device as compared to Pinard (which had 15%
abnormal FHRs) [16]. This study was conducted at the
National hospital in Harare, Zimbabwe, at a time with
fairly good health services (1994), and appointed re-
search midwives were engaged in the study, increasing
Fig. 1 Consort flow diagram






Maternal Age (Years) Mean ± SD 25.8 ± 5.7 26.4 ± 6.6
Maternal Gravida 1 1286 (47.9) 1603 (46.5) 0.274
2 to 5 975 (36.3) 1276 (37.0) 0.577
> 5 423 (15.8) 568 (16.5) 0.449
Gestational Age (Weeks) Mean ± SD 38.3 ± 1.5 37.8 ± 1.4
> 40 95 (3.5) 101 (2.9) 0.179
Gender Male 1471 (56.0) 1824 (53.6) 0.141
Female 1213 (44.0) 1623 (46.4)
Birth Weight (Grams) Mean ± SD 3356 ± 463 33,804 ± 455
< 2500 108 (4.0) 180 (5.2) 0.028
≥ 2500 2576 (96.0) 3267 (94.8)
Values given are n (%) unless otherwise stated
Mdoe et al. BMC Pregnancy and Childbirth  (2018) 18:134 Page 4 of 8
the ability to follow the recommended frequency for
FHR measurements [16]. In 2012–13, Byaruhanga R et
al. compared the same devices as used in our study in
a peri-urban setting [20]. FHR abnormalities were de-
tected in 7.6% vs 4.7% of the deliveries in the Free Play
Doppler and Pinard arm, respectively, but with no dif-
ferences in perinatal outcome. They speculate that
there might have been an undocumented delay be-
tween recognition of fetal distress and obstetrical ac-
tions. Our study was conducted in a rural setting, and
intermittent FHR assessments were done by the
midwives.
In addition, several other important factors may have
influenced our results. Notably this was the initial time
that a randomized trial was conducted in this rural hos-
pital, with unique factors that limited the recruitment
and consent seeking process. Thus in this setting women
typically arrive late in labor, and many low-risk women
were not eligible due to late arrival with cervical dilata-
tion ≥7 on admission. In addition, FHR assessment was
not performed in 9% of admissions, which led to the ex-
clusion of these women. Therefore, only 55% of the total
cohort fulfilled the inclusion criteria. In addition, only
44% of these eligible women agreed to participate in the
study, creating a potential selection bias. There might be
several reasons behind the low consent rates. First,
women in labor may not be capable of receiving infor-
mation and making informed decisions. Second, the
midwife/patient ratio in this hospital is low, leading to a
considerable time constraint for midwives on duty,
which may have influenced their ability to spend ad-
equate time recruiting women (8% of the eligible
women were never approached for consent). [22, 23]
Third, some midwives may have had strong prefer-
ences for which device they trusted the most, and
therefore wanted to use, potentially affecting their
willingness to recruit participants, and to follow the
study protocol. Fourth, laboring women might have
felt dependent on the midwife at the time of obtaining
Table 3 Comparison of fetal heart rate (FHR), newborn characteristics and perinatal outcome between the eligible women who
consented to participate and those with no consent (refused or not asked for consent)





FHR abnormalities 112 (4.2) 177 (5.1) 0.078
Abnormal FHR 98 (3.6) 119 (3.5) 0.676
Not measured 14 (0.5) 58 (1.7) 0.001
Time interval from admission to first abnormal FHR assessment (minutes) 466 ± 349 394 ± 357 0.173
Time interval abnormal FHR to birth (minutes) 93 ± 127 104 ± 179 0.624
Time interval last recorded FHR to birth (minutes) 79 ± 187 89 ± 194 0.059
Cesarean section 559 (20.8) 848 (24.6) 0.001
Apgar score < 7 at
1 Minute 89 (3.3) 113 (3.3) 0.937
5 Minutes 21 (0.8) 33 (1.0) 0.466
Bag mask ventilation 162 (6.0) 239 (6.9) 0.158
Adverse neonatal outcome 67 (2.5) 111 (3.2) 0.094
Fresh stillbirths 7 (0.3) 23 (0.7) 0.023
Early neonatal deaths 14 (0.5) 17 (0.5) 0.890
Admitted neonatal area 46 (1.7) 71 (2.1) 0.471
Values given are n (%)
Table 4 Characteristics of women and neonates included in the





Maternal Age (Years) Mean ± SD 25.4 ± 6.7 24.8 ± 6.2
Maternal Gravida 1 667 (48.5) 592 (45.2)
2 to 5 492 (35.8) 487 (37.2)
> 5 216 (15.7) 230 (17.6)
Gestational Age (Weeks) Mean ± SD 38.1 ± 1.6 38.2 ± 1.7
> 40 51 (3.7) 51 (3.9)
Gender Male 770 (56.0) 701 (53.6)
Female 605 (44.0) 608 (46.4)
Birth Weight (Grams) Mean ± SD 3286 ± 473 32,804 ± 433
< 2500 59 (4.3) 49 (3.7)
≥ 2500 1316 (95.7) 1260 (96.3)
Values given are n (%) unless otherwise stated
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consent, and this may have influenced their free
choice.
Comparing the eligible non-randomized with the ran-
domized group, several important differences stand out.
First, more non randomized women did not have FHR
assessed during labor, second, time from detection of an
abnormal FHR to birth was longer, and third there was a
higher incidence of CS (24.6%) and FSB (0.7%) in the
non-randomized group. These differences may represent
a positive Hawthorne effect of being included in the
study. The qualities of FHR assessments followed by
timely obstetrical interventions seem to be enhanced in
the trial population, with either device used, as com-
pared to daily routine care. Interestingly, CS rate in the
non-eligible sub-population, when including high-risk
deliveries, was almost identical to the CS rate in the trial
population, i.e. 20.9% vs 20.8%, respectively. Of the
women in the not-eligible group, 2% were admitted with
an absent FHR, FHR assessments were not performed in
as many as 21% of admissions, time intervals from
admission to birth were shorter (many of these women
arrived late in labor), but time intervals from detection
of an abnormal FHR to birth were considerably longer.
Adverse outcomes were highest in this not-eligible
group, maybe reflecting less timely expedited deliveries.
There are several limitations to this randomized trial,
reflecting a typical rural sub-Saharan African setting. We
report a potential selection bias and a potential positive
Hawthorn effect of being enrolled in the trial. Further-
more, a 1:1 midwife/patient ratio was impossible to
achieve; therefore, FHR measurements were likely not
performed according to recommended guidelines, based
on the fact that more than 9% of the women never had a
FHR assessed, and that the mean time interval from the
last FHR assessment to birth was approximately 1.5 h,
much longer than recommended, a finding consistent
with previous reports [22, 23]. Complying with the rec-
ommended guidelines for optimal intermittent FHR
monitoring is reported to require a 1:1 midwife/patient
ratio [24–26], and our findings are not representative of
hospitals where FHR measurements are done according
to guidelines for intermittent FHR assessments. Finally,
at HLH, fetoscopes (often homemade) have been
common equipment for FHR assessments for decades.
Although many hand-held wind-up Dopplers were pro-
vided, available also for women not enrolled in the trial,
Doppler was rarely used outside the trial. In addition,
the fetoscope was used to verify FHR in the Doppler
arm more often than the opposite, i.e. Doppler used to
verify FHR in the fetoscope arm. This may be explained
by an uncertainty related to the new device that also
may have influenced the results.
The strength of the study is firstly that it represents a
rural hospital with all the typical challenges related to
clinical care and patient population, as in other rural
low-resource settings. Secondly, at the same time, a
unique research infrastructure has been established in
parallel to the clinical operations, employing separate
staff, not involved with clinical management. Trained
research assistants have continuously observed and col-
lected data from every birth since 2009, standard operat-
ing procedures regulate all research operations, rigorous






FHR abnormalities 49 (3.5) 66 (5.0) 1.42 (0.98, 2.03) 0.064
Abnormal FHR 42 (3.1) 56 (4.2) 1.38 (0.93, 2.04) 0.109
Not measured FHR 7 (0.5) 10 (0.7) 1.5 (0.57, 3.93) 0.40
Time interval admission to first abnormal FHR assessment (minutes) 520 ± 386 429 ± 321 90.2 (−63.9, 244.3) 0.248
Time interval abnormal FHR to birth (minutes) 90.8 ± 122 95.1 ± 132 −4.34 (−58.2, 49.5) 0.873
Time interval last recorded FHR to birth (minutes) 79.1 ± 185 79.5 ± 188 −0.43 (−14.6, 13.8) 0.952
Cesarean Section 286 (20.8) 273 (20.9) 1.00 (0.87, 1.16) 0.972
Bag mask ventilation 82 (6.0) 80 (6.1) 1.03 (0.76, 1.38) 0.872
Apgar Score < 7
1 Minute 46 (3.3) 43 (3.3) 0.98 (0.65, 1.48) 0.921
5 Minutes 11 (0.8) 10 (0.8) 0.95 (0.40, 2.24) 0.914
Adverse perinatal outcome 35 (2.5) 32 (2.4) 0.96 (0.59, 1.54) 0.867
Fresh stillbirths 4 (0.3) 3 (0.2) 0.78 (0.17, 3.51) 0.527
Early neonatal deaths 5 (0.4) 9 (0.7) 1.89 (0.63, 5.63) 0.244
Admitted neonatal area 26 (1.9) 20 (1.5) 0.81 (0.45, 1.44) 0.475
Values given are n (%) unless otherwise stated
aEffect measure = Risk Ratio for categorical variables and Mean Difference for continuous variables
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data quality control systems involve several levels and
different people (manually and electronically), and
double independent entry of all data is performed
locally, before external control. This comprehensive
research set-up has enabled collection of high quality
data obtained from all deliveries, including patients not
involved in the randomized trial. Finally, a randomized
trial design provides high level quality evidence.
Conclusion
This randomized trial fails to demonstrate significant
differences in detection of abnormal FHRs and perinatal
outcomes, comparing a fetoscope with a hand-held
Doppler for intermittent FHR assessment, in a rural
sub-Saharan hospital, with a low midwife/patient ratio.
FHR measurements were not performed as often as
recommended in the international guidelines, and we
speculate that the true frequency of FHR abnormalities
is higher in both arms. Conducting a randomized trial in
a rural low resource setting is associated with major
challenges and requires a minimum setup as described
above.
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